Company
Bristol-Myers Squibb Co BMY
Tracked across 6 disclosed holders on Protégé.
3 tracked investors, latest 13F quarter ending 30 Jun 2026 · 2 members of Congress · 1 executive · latest filing 14 Aug 2026
Held by these investors
| Investor | Weight in portfolio | Value (13F) | Quarter ending |
|---|---|---|---|
| Bill Miller | 0.9% | $4.0M | 2026-06-30 |
| Cliff Asness | 0.5% | $1.6B | 2026-06-30 |
| Two Sigma Investments | 0.5% | $581.1M | 2026-06-30 |
Members of Congress who disclosed trades
| Politician | Disclosed activity | Est. net |
|---|---|---|
| Mike Kelly | 0 buys / 1 sell | -$33K |
| Julie Johnson | 0 buys / 1 sell | -$8K |
Company executives who disclosed trades
| Executive | Disclosed activity | Net |
|---|---|---|
| Christopher Boerner | 1 buy / 0 sells | $110K |
Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.